nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A4—type 2 diabetes mellitus	0.293	1	CbGaD
Argatroban—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0555	0.146	CbGbCtD
Argatroban—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0443	0.116	CbGbCtD
Argatroban—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0395	0.104	CbGbCtD
Argatroban—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0361	0.0949	CbGbCtD
Argatroban—CYP3A5—Losartan—type 2 diabetes mellitus	0.0343	0.0901	CbGbCtD
Argatroban—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0316	0.083	CbGbCtD
Argatroban—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0285	0.075	CbGbCtD
Argatroban—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0216	0.0569	CbGbCtD
Argatroban—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0207	0.0545	CbGbCtD
Argatroban—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0207	0.0545	CbGbCtD
Argatroban—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0196	0.0515	CbGbCtD
Argatroban—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0146	0.0384	CbGbCtD
Argatroban—CYP3A4—Losartan—type 2 diabetes mellitus	0.0134	0.0351	CbGbCtD
Argatroban—F2—leg—type 2 diabetes mellitus	0.0101	0.249	CbGeAlD
Argatroban—F2—hindlimb—type 2 diabetes mellitus	0.009	0.222	CbGeAlD
Argatroban—F2—artery—type 2 diabetes mellitus	0.00551	0.136	CbGeAlD
Argatroban—F2—endothelium—type 2 diabetes mellitus	0.00466	0.115	CbGeAlD
Argatroban—F2—cardiovascular system—type 2 diabetes mellitus	0.00192	0.0473	CbGeAlD
Argatroban—F2—kidney—type 2 diabetes mellitus	0.00188	0.0463	CbGeAlD
Argatroban—F2—liver—type 2 diabetes mellitus	0.00119	0.0293	CbGeAlD
Argatroban—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.00107	0.0265	CbGeAlD
Argatroban—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000864	0.0213	CbGeAlD
Argatroban—CYP3A5—kidney—type 2 diabetes mellitus	0.000759	0.0187	CbGeAlD
Argatroban—CYP3A5—pancreas—type 2 diabetes mellitus	0.000754	0.0186	CbGeAlD
Argatroban—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000739	0.0183	CbGeAlD
Argatroban—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000684	0.0169	CbGeAlD
Argatroban—CYP3A4—kidney—type 2 diabetes mellitus	0.00057	0.0141	CbGeAlD
Argatroban—CYP3A5—liver—type 2 diabetes mellitus	0.00048	0.0118	CbGeAlD
Argatroban—CYP3A4—liver—type 2 diabetes mellitus	0.00036	0.00889	CbGeAlD
Argatroban—Infection—Bromocriptine—type 2 diabetes mellitus	0.000317	0.00183	CcSEcCtD
Argatroban—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000316	0.00182	CcSEcCtD
Argatroban—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.000315	0.00182	CcSEcCtD
Argatroban—Nausea—Nateglinide—type 2 diabetes mellitus	0.000315	0.00181	CcSEcCtD
Argatroban—Bradycardia—Metformin—type 2 diabetes mellitus	0.000314	0.00181	CcSEcCtD
Argatroban—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000314	0.00181	CcSEcCtD
Argatroban—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000314	0.00181	CcSEcCtD
Argatroban—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000313	0.0018	CcSEcCtD
Argatroban—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000312	0.00179	CcSEcCtD
Argatroban—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000312	0.00179	CcSEcCtD
Argatroban—Back pain—Gliclazide—type 2 diabetes mellitus	0.000311	0.00179	CcSEcCtD
Argatroban—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000311	0.00179	CcSEcCtD
Argatroban—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00031	0.00179	CcSEcCtD
Argatroban—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000308	0.00177	CcSEcCtD
Argatroban—Pneumonia—Losartan—type 2 diabetes mellitus	0.000307	0.00177	CcSEcCtD
Argatroban—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000306	0.00176	CcSEcCtD
Argatroban—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000305	0.00175	CcSEcCtD
Argatroban—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000302	0.00174	CcSEcCtD
Argatroban—Pain—Sitagliptin—type 2 diabetes mellitus	0.000302	0.00174	CcSEcCtD
Argatroban—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.0003	0.00173	CcSEcCtD
Argatroban—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000299	0.00172	CcSEcCtD
Argatroban—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000298	0.00172	CcSEcCtD
Argatroban—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.000297	0.00171	CcSEcCtD
Argatroban—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000297	0.00171	CcSEcCtD
Argatroban—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000296	0.00171	CcSEcCtD
Argatroban—Confusional state—Glyburide—type 2 diabetes mellitus	0.000294	0.0017	CcSEcCtD
Argatroban—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000292	0.00168	CcSEcCtD
Argatroban—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000291	0.00168	CcSEcCtD
Argatroban—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000291	0.00167	CcSEcCtD
Argatroban—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000289	0.00167	CcSEcCtD
Argatroban—Rash—Repaglinide—type 2 diabetes mellitus	0.000289	0.00166	CcSEcCtD
Argatroban—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000289	0.00166	CcSEcCtD
Argatroban—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000289	0.00166	CcSEcCtD
Argatroban—Headache—Repaglinide—type 2 diabetes mellitus	0.000287	0.00165	CcSEcCtD
Argatroban—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000287	0.00165	CcSEcCtD
Argatroban—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000286	0.00165	CcSEcCtD
Argatroban—Back pain—Valsartan—type 2 diabetes mellitus	0.000285	0.00164	CcSEcCtD
Argatroban—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000285	0.00164	CcSEcCtD
Argatroban—Back pain—Orlistat—type 2 diabetes mellitus	0.000282	0.00162	CcSEcCtD
Argatroban—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000281	0.00162	CcSEcCtD
Argatroban—Cough—Gliclazide—type 2 diabetes mellitus	0.00028	0.00161	CcSEcCtD
Argatroban—Angiopathy—Metformin—type 2 diabetes mellitus	0.00028	0.00161	CcSEcCtD
Argatroban—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00028	0.00161	CcSEcCtD
Argatroban—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000279	0.00161	CcSEcCtD
Argatroban—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000279	0.00161	CcSEcCtD
Argatroban—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000276	0.00159	CcSEcCtD
Argatroban—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000273	0.00157	CcSEcCtD
Argatroban—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000273	0.00157	CcSEcCtD
Argatroban—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000273	0.00157	CcSEcCtD
Argatroban—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000273	0.00157	CcSEcCtD
Argatroban—Hypotension—Glyburide—type 2 diabetes mellitus	0.000273	0.00157	CcSEcCtD
Argatroban—Nausea—Repaglinide—type 2 diabetes mellitus	0.000272	0.00157	CcSEcCtD
Argatroban—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000271	0.00156	CcSEcCtD
Argatroban—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000268	0.00154	CcSEcCtD
Argatroban—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000264	0.00152	CcSEcCtD
Argatroban—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000264	0.00152	CcSEcCtD
Argatroban—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000263	0.00152	CcSEcCtD
Argatroban—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000261	0.0015	CcSEcCtD
Argatroban—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000261	0.0015	CcSEcCtD
Argatroban—Infection—Gliclazide—type 2 diabetes mellitus	0.00026	0.0015	CcSEcCtD
Argatroban—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00026	0.0015	CcSEcCtD
Argatroban—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00026	0.0015	CcSEcCtD
Argatroban—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00026	0.00149	CcSEcCtD
Argatroban—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000258	0.00149	CcSEcCtD
Argatroban—Cough—Valsartan—type 2 diabetes mellitus	0.000257	0.00148	CcSEcCtD
Argatroban—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000257	0.00148	CcSEcCtD
Argatroban—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000257	0.00148	CcSEcCtD
Argatroban—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000257	0.00148	CcSEcCtD
Argatroban—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000256	0.00147	CcSEcCtD
Argatroban—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000255	0.00147	CcSEcCtD
Argatroban—Cough—Orlistat—type 2 diabetes mellitus	0.000254	0.00147	CcSEcCtD
Argatroban—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000252	0.00145	CcSEcCtD
Argatroban—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000252	0.00145	CcSEcCtD
Argatroban—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000252	0.00145	CcSEcCtD
Argatroban—Chest pain—Valsartan—type 2 diabetes mellitus	0.000251	0.00145	CcSEcCtD
Argatroban—Dizziness—Glipizide—type 2 diabetes mellitus	0.000251	0.00144	CcSEcCtD
Argatroban—Angiopathy—Losartan—type 2 diabetes mellitus	0.000249	0.00143	CcSEcCtD
Argatroban—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000249	0.00143	CcSEcCtD
Argatroban—Chest pain—Orlistat—type 2 diabetes mellitus	0.000248	0.00143	CcSEcCtD
Argatroban—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000245	0.00141	CcSEcCtD
Argatroban—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000242	0.00139	CcSEcCtD
Argatroban—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000241	0.00139	CcSEcCtD
Argatroban—Vomiting—Glipizide—type 2 diabetes mellitus	0.000241	0.00139	CcSEcCtD
Argatroban—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000241	0.00139	CcSEcCtD
Argatroban—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00024	0.00138	CcSEcCtD
Argatroban—Infection—Valsartan—type 2 diabetes mellitus	0.000239	0.00138	CcSEcCtD
Argatroban—Rash—Glipizide—type 2 diabetes mellitus	0.000239	0.00138	CcSEcCtD
Argatroban—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000239	0.00138	CcSEcCtD
Argatroban—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000239	0.00137	CcSEcCtD
Argatroban—Headache—Glipizide—type 2 diabetes mellitus	0.000238	0.00137	CcSEcCtD
Argatroban—Infection—Orlistat—type 2 diabetes mellitus	0.000236	0.00136	CcSEcCtD
Argatroban—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000234	0.00135	CcSEcCtD
Argatroban—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000234	0.00135	CcSEcCtD
Argatroban—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000233	0.00134	CcSEcCtD
Argatroban—Back pain—Losartan—type 2 diabetes mellitus	0.000231	0.00133	CcSEcCtD
Argatroban—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000231	0.00133	CcSEcCtD
Argatroban—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000231	0.00133	CcSEcCtD
Argatroban—Chest pain—Metformin—type 2 diabetes mellitus	0.000229	0.00132	CcSEcCtD
Argatroban—Headache—Pioglitazone—type 2 diabetes mellitus	0.000228	0.00131	CcSEcCtD
Argatroban—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000226	0.0013	CcSEcCtD
Argatroban—Nausea—Glipizide—type 2 diabetes mellitus	0.000225	0.0013	CcSEcCtD
Argatroban—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000225	0.0013	CcSEcCtD
Argatroban—Hypotension—Valsartan—type 2 diabetes mellitus	0.000225	0.0013	CcSEcCtD
Argatroban—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000224	0.00129	CcSEcCtD
Argatroban—Pain—Gliclazide—type 2 diabetes mellitus	0.000224	0.00129	CcSEcCtD
Argatroban—Constipation—Gliclazide—type 2 diabetes mellitus	0.000224	0.00129	CcSEcCtD
Argatroban—Rash—Glimepiride—type 2 diabetes mellitus	0.000223	0.00129	CcSEcCtD
Argatroban—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000223	0.00128	CcSEcCtD
Argatroban—Rash—Sitagliptin—type 2 diabetes mellitus	0.000222	0.00128	CcSEcCtD
Argatroban—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000222	0.00128	CcSEcCtD
Argatroban—Headache—Glimepiride—type 2 diabetes mellitus	0.000222	0.00128	CcSEcCtD
Argatroban—Cough—Irbesartan—type 2 diabetes mellitus	0.000221	0.00127	CcSEcCtD
Argatroban—Headache—Sitagliptin—type 2 diabetes mellitus	0.000221	0.00127	CcSEcCtD
Argatroban—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000218	0.00126	CcSEcCtD
Argatroban—Infection—Metformin—type 2 diabetes mellitus	0.000218	0.00125	CcSEcCtD
Argatroban—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000216	0.00124	CcSEcCtD
Argatroban—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000216	0.00124	CcSEcCtD
Argatroban—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000215	0.00124	CcSEcCtD
Argatroban—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000215	0.00124	CcSEcCtD
Argatroban—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000214	0.00123	CcSEcCtD
Argatroban—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000212	0.00122	CcSEcCtD
Argatroban—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000211	0.00122	CcSEcCtD
Argatroban—Nausea—Glimepiride—type 2 diabetes mellitus	0.00021	0.00121	CcSEcCtD
Argatroban—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00021	0.00121	CcSEcCtD
Argatroban—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000209	0.00121	CcSEcCtD
Argatroban—Cough—Losartan—type 2 diabetes mellitus	0.000208	0.0012	CcSEcCtD
Argatroban—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000208	0.0012	CcSEcCtD
Argatroban—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000207	0.00119	CcSEcCtD
Argatroban—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000207	0.00119	CcSEcCtD
Argatroban—Constipation—Valsartan—type 2 diabetes mellitus	0.000206	0.00119	CcSEcCtD
Argatroban—Infection—Irbesartan—type 2 diabetes mellitus	0.000206	0.00118	CcSEcCtD
Argatroban—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000205	0.00118	CcSEcCtD
Argatroban—Hypotension—Metformin—type 2 diabetes mellitus	0.000205	0.00118	CcSEcCtD
Argatroban—Pain—Orlistat—type 2 diabetes mellitus	0.000203	0.00117	CcSEcCtD
Argatroban—Chest pain—Losartan—type 2 diabetes mellitus	0.000203	0.00117	CcSEcCtD
Argatroban—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000203	0.00117	CcSEcCtD
Argatroban—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000202	0.00116	CcSEcCtD
Argatroban—Rash—Bromocriptine—type 2 diabetes mellitus	0.000201	0.00116	CcSEcCtD
Argatroban—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000201	0.00116	CcSEcCtD
Argatroban—Headache—Bromocriptine—type 2 diabetes mellitus	0.0002	0.00115	CcSEcCtD
Argatroban—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.0002	0.00115	CcSEcCtD
Argatroban—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000197	0.00113	CcSEcCtD
Argatroban—Confusional state—Losartan—type 2 diabetes mellitus	0.000196	0.00113	CcSEcCtD
Argatroban—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000196	0.00113	CcSEcCtD
Argatroban—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000196	0.00113	CcSEcCtD
Argatroban—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000195	0.00112	CcSEcCtD
Argatroban—Infection—Losartan—type 2 diabetes mellitus	0.000193	0.00111	CcSEcCtD
Argatroban—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000193	0.00111	CcSEcCtD
Argatroban—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000193	0.00111	CcSEcCtD
Argatroban—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000193	0.00111	CcSEcCtD
Argatroban—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00019	0.0011	CcSEcCtD
Argatroban—Tachycardia—Losartan—type 2 diabetes mellitus	0.00019	0.00109	CcSEcCtD
Argatroban—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00019	0.00109	CcSEcCtD
Argatroban—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000189	0.00109	CcSEcCtD
Argatroban—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000188	0.00108	CcSEcCtD
Argatroban—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000188	0.00108	CcSEcCtD
Argatroban—Constipation—Metformin—type 2 diabetes mellitus	0.000188	0.00108	CcSEcCtD
Argatroban—Vomiting—Glyburide—type 2 diabetes mellitus	0.000186	0.00107	CcSEcCtD
Argatroban—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000185	0.00106	CcSEcCtD
Argatroban—Rash—Glyburide—type 2 diabetes mellitus	0.000184	0.00106	CcSEcCtD
Argatroban—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000184	0.00106	CcSEcCtD
Argatroban—Headache—Glyburide—type 2 diabetes mellitus	0.000183	0.00105	CcSEcCtD
Argatroban—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000182	0.00105	CcSEcCtD
Argatroban—Hypotension—Losartan—type 2 diabetes mellitus	0.000182	0.00105	CcSEcCtD
Argatroban—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000181	0.00104	CcSEcCtD
Argatroban—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000179	0.00103	CcSEcCtD
Argatroban—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000179	0.00103	CcSEcCtD
Argatroban—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000179	0.00103	CcSEcCtD
Argatroban—Cough—Ramipril—type 2 diabetes mellitus	0.000179	0.00103	CcSEcCtD
Argatroban—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000177	0.00102	CcSEcCtD
Argatroban—Pain—Irbesartan—type 2 diabetes mellitus	0.000177	0.00102	CcSEcCtD
Argatroban—Constipation—Irbesartan—type 2 diabetes mellitus	0.000177	0.00102	CcSEcCtD
Argatroban—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000175	0.00101	CcSEcCtD
Argatroban—Chest pain—Ramipril—type 2 diabetes mellitus	0.000174	0.001	CcSEcCtD
Argatroban—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000174	0.001	CcSEcCtD
Argatroban—Nausea—Glyburide—type 2 diabetes mellitus	0.000173	0.000999	CcSEcCtD
Argatroban—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000173	0.000998	CcSEcCtD
Argatroban—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000173	0.000998	CcSEcCtD
Argatroban—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000171	0.000987	CcSEcCtD
Argatroban—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000171	0.000982	CcSEcCtD
Argatroban—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000169	0.000975	CcSEcCtD
Argatroban—Confusional state—Ramipril—type 2 diabetes mellitus	0.000168	0.00097	CcSEcCtD
Argatroban—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000167	0.00096	CcSEcCtD
Argatroban—Pain—Losartan—type 2 diabetes mellitus	0.000167	0.000959	CcSEcCtD
Argatroban—Constipation—Losartan—type 2 diabetes mellitus	0.000167	0.000959	CcSEcCtD
Argatroban—Rash—Gliclazide—type 2 diabetes mellitus	0.000165	0.000952	CcSEcCtD
Argatroban—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000165	0.000951	CcSEcCtD
Argatroban—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000165	0.000949	CcSEcCtD
Argatroban—Headache—Gliclazide—type 2 diabetes mellitus	0.000164	0.000946	CcSEcCtD
Argatroban—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000164	0.000942	CcSEcCtD
Argatroban—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000164	0.000942	CcSEcCtD
Argatroban—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000163	0.000939	CcSEcCtD
Argatroban—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000163	0.000938	CcSEcCtD
Argatroban—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00016	0.000924	CcSEcCtD
Argatroban—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000159	0.000917	CcSEcCtD
Argatroban—Dizziness—Valsartan—type 2 diabetes mellitus	0.000159	0.000917	CcSEcCtD
Argatroban—Dizziness—Orlistat—type 2 diabetes mellitus	0.000157	0.000906	CcSEcCtD
Argatroban—Hypotension—Ramipril—type 2 diabetes mellitus	0.000156	0.000899	CcSEcCtD
Argatroban—Nausea—Gliclazide—type 2 diabetes mellitus	0.000156	0.000897	CcSEcCtD
Argatroban—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000154	0.000887	CcSEcCtD
Argatroban—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000154	0.000887	CcSEcCtD
Argatroban—Vomiting—Valsartan—type 2 diabetes mellitus	0.000153	0.000882	CcSEcCtD
Argatroban—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000152	0.000878	CcSEcCtD
Argatroban—Rash—Valsartan—type 2 diabetes mellitus	0.000152	0.000874	CcSEcCtD
Argatroban—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000152	0.000874	CcSEcCtD
Argatroban—Vomiting—Orlistat—type 2 diabetes mellitus	0.000151	0.000871	CcSEcCtD
Argatroban—Headache—Valsartan—type 2 diabetes mellitus	0.000151	0.000869	CcSEcCtD
Argatroban—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00015	0.000864	CcSEcCtD
Argatroban—Rash—Orlistat—type 2 diabetes mellitus	0.00015	0.000864	CcSEcCtD
Argatroban—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00015	0.000863	CcSEcCtD
Argatroban—Headache—Orlistat—type 2 diabetes mellitus	0.000149	0.000859	CcSEcCtD
Argatroban—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000149	0.000857	CcSEcCtD
Argatroban—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000147	0.000847	CcSEcCtD
Argatroban—Dizziness—Metformin—type 2 diabetes mellitus	0.000145	0.000835	CcSEcCtD
Argatroban—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000144	0.00083	CcSEcCtD
Argatroban—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000143	0.000826	CcSEcCtD
Argatroban—Nausea—Valsartan—type 2 diabetes mellitus	0.000143	0.000824	CcSEcCtD
Argatroban—Constipation—Ramipril—type 2 diabetes mellitus	0.000143	0.000822	CcSEcCtD
Argatroban—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000142	0.000815	CcSEcCtD
Argatroban—Nausea—Orlistat—type 2 diabetes mellitus	0.000141	0.000814	CcSEcCtD
Argatroban—Vomiting—Metformin—type 2 diabetes mellitus	0.000139	0.000803	CcSEcCtD
Argatroban—Rash—Metformin—type 2 diabetes mellitus	0.000138	0.000796	CcSEcCtD
Argatroban—Dermatitis—Metformin—type 2 diabetes mellitus	0.000138	0.000796	CcSEcCtD
Argatroban—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000138	0.000793	CcSEcCtD
Argatroban—Headache—Metformin—type 2 diabetes mellitus	0.000137	0.000791	CcSEcCtD
Argatroban—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000137	0.000788	CcSEcCtD
Argatroban—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000137	0.000786	CcSEcCtD
Argatroban—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000133	0.000767	CcSEcCtD
Argatroban—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000132	0.00076	CcSEcCtD
Argatroban—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000132	0.00076	CcSEcCtD
Argatroban—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000132	0.000758	CcSEcCtD
Argatroban—Rash—Irbesartan—type 2 diabetes mellitus	0.00013	0.000751	CcSEcCtD
Argatroban—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00013	0.000751	CcSEcCtD
Argatroban—Nausea—Metformin—type 2 diabetes mellitus	0.00013	0.00075	CcSEcCtD
Argatroban—Headache—Irbesartan—type 2 diabetes mellitus	0.00013	0.000747	CcSEcCtD
Argatroban—Dizziness—Losartan—type 2 diabetes mellitus	0.000129	0.000742	CcSEcCtD
Argatroban—Vomiting—Losartan—type 2 diabetes mellitus	0.000124	0.000713	CcSEcCtD
Argatroban—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000123	0.000709	CcSEcCtD
Argatroban—Nausea—Irbesartan—type 2 diabetes mellitus	0.000123	0.000708	CcSEcCtD
Argatroban—Rash—Losartan—type 2 diabetes mellitus	0.000123	0.000707	CcSEcCtD
Argatroban—Dermatitis—Losartan—type 2 diabetes mellitus	0.000123	0.000707	CcSEcCtD
Argatroban—Headache—Losartan—type 2 diabetes mellitus	0.000122	0.000703	CcSEcCtD
Argatroban—Nausea—Losartan—type 2 diabetes mellitus	0.000116	0.000666	CcSEcCtD
Argatroban—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000114	0.000658	CcSEcCtD
Argatroban—Dizziness—Ramipril—type 2 diabetes mellitus	0.00011	0.000636	CcSEcCtD
Argatroban—Vomiting—Ramipril—type 2 diabetes mellitus	0.000106	0.000612	CcSEcCtD
Argatroban—Rash—Ramipril—type 2 diabetes mellitus	0.000105	0.000606	CcSEcCtD
Argatroban—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000105	0.000606	CcSEcCtD
Argatroban—Headache—Ramipril—type 2 diabetes mellitus	0.000105	0.000603	CcSEcCtD
Argatroban—Nausea—Ramipril—type 2 diabetes mellitus	9.92e-05	0.000571	CcSEcCtD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	3.38e-05	0.0003	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC5A4—type 2 diabetes mellitus	3.38e-05	0.0003	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MAT1A—type 2 diabetes mellitus	3.38e-05	0.0003	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	3.37e-05	0.000299	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.34e-05	0.000297	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.26e-05	0.000289	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ND1—type 2 diabetes mellitus	3.26e-05	0.000289	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HBA2—type 2 diabetes mellitus	3.26e-05	0.000289	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ENPP1—type 2 diabetes mellitus	3.26e-05	0.000289	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—G6PC—type 2 diabetes mellitus	3.26e-05	0.000289	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	3.23e-05	0.000286	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	3.18e-05	0.000282	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GCGR—type 2 diabetes mellitus	3.16e-05	0.00028	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—C3—type 2 diabetes mellitus	3.1e-05	0.000275	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—INS—type 2 diabetes mellitus	3.07e-05	0.000273	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	3.06e-05	0.000272	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	3.05e-05	0.000271	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.03e-05	0.000269	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CCL2—type 2 diabetes mellitus	3.02e-05	0.000268	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.01e-05	0.000267	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—INSR—type 2 diabetes mellitus	2.99e-05	0.000266	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—OXCT1—type 2 diabetes mellitus	2.98e-05	0.000265	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYTB—type 2 diabetes mellitus	2.98e-05	0.000265	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—IGF1—type 2 diabetes mellitus	2.97e-05	0.000264	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	2.95e-05	0.000262	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	2.94e-05	0.000261	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	2.94e-05	0.000261	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	2.92e-05	0.000259	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SRD5A1—type 2 diabetes mellitus	2.91e-05	0.000258	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	2.88e-05	0.000256	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.82e-05	0.00025	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—C3—type 2 diabetes mellitus	2.82e-05	0.00025	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	2.8e-05	0.000248	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.78e-05	0.000247	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HSD17B3—type 2 diabetes mellitus	2.77e-05	0.000246	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ACACA—type 2 diabetes mellitus	2.77e-05	0.000246	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—STAR—type 2 diabetes mellitus	2.77e-05	0.000246	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.72e-05	0.000242	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.72e-05	0.000241	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.72e-05	0.000241	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.68e-05	0.000238	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCC8—type 2 diabetes mellitus	2.66e-05	0.000236	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CBS—type 2 diabetes mellitus	2.66e-05	0.000236	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.64e-05	0.000235	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.63e-05	0.000234	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.63e-05	0.000234	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.59e-05	0.00023	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.58e-05	0.000229	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.58e-05	0.000229	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—COX2—type 2 diabetes mellitus	2.56e-05	0.000227	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC5A2—type 2 diabetes mellitus	2.56e-05	0.000227	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.54e-05	0.000226	CbGpPWpGaD
Argatroban—F2—Hemostasis—SRC—type 2 diabetes mellitus	2.53e-05	0.000225	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NCOA6—type 2 diabetes mellitus	2.51e-05	0.000223	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.47e-05	0.00022	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HSD11B1—type 2 diabetes mellitus	2.47e-05	0.000219	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—UCP2—type 2 diabetes mellitus	2.47e-05	0.000219	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—UCP3—type 2 diabetes mellitus	2.47e-05	0.000219	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—type 2 diabetes mellitus	2.47e-05	0.000219	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.4e-05	0.000213	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.39e-05	0.000212	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GCG—type 2 diabetes mellitus	2.36e-05	0.000209	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.36e-05	0.000209	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PCK1—type 2 diabetes mellitus	2.32e-05	0.000206	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.32e-05	0.000206	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.31e-05	0.000205	CbGpPWpGaD
Argatroban—F2—Hemostasis—TGFB1—type 2 diabetes mellitus	2.26e-05	0.000201	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.21e-05	0.000196	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HK1—type 2 diabetes mellitus	2.18e-05	0.000193	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.17e-05	0.000192	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.16e-05	0.000192	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.15e-05	0.000191	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—KCNJ11—type 2 diabetes mellitus	2.1e-05	0.000186	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GCKR—type 2 diabetes mellitus	2.1e-05	0.000186	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LPA—type 2 diabetes mellitus	2.1e-05	0.000186	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HSD3B2—type 2 diabetes mellitus	2.1e-05	0.000186	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.05e-05	0.000182	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.03e-05	0.00018	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALDOB—type 2 diabetes mellitus	2.01e-05	0.000179	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP3—type 2 diabetes mellitus	2e-05	0.000178	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AVP—type 2 diabetes mellitus	2e-05	0.000178	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.99e-05	0.000177	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.99e-05	0.000176	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.97e-05	0.000174	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.94e-05	0.000172	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.93e-05	0.000171	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.91e-05	0.000169	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.88e-05	0.000167	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.88e-05	0.000167	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GLP1R—type 2 diabetes mellitus	1.87e-05	0.000166	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.85e-05	0.000164	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.81e-05	0.000161	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.78e-05	0.000158	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.78e-05	0.000158	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC2A2—type 2 diabetes mellitus	1.75e-05	0.000155	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.73e-05	0.000154	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CPT1A—type 2 diabetes mellitus	1.71e-05	0.000152	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTR—type 2 diabetes mellitus	1.71e-05	0.000152	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.7e-05	0.000151	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.7e-05	0.000151	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NAMPT—type 2 diabetes mellitus	1.68e-05	0.000149	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LIPC—type 2 diabetes mellitus	1.67e-05	0.000148	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HBA1—type 2 diabetes mellitus	1.67e-05	0.000148	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GCK—type 2 diabetes mellitus	1.67e-05	0.000148	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—C3—type 2 diabetes mellitus	1.66e-05	0.000148	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP11A1—type 2 diabetes mellitus	1.66e-05	0.000147	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC9A1—type 2 diabetes mellitus	1.63e-05	0.000145	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CETP—type 2 diabetes mellitus	1.61e-05	0.000143	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.59e-05	0.000141	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.58e-05	0.000141	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.58e-05	0.00014	CbGpPWpGaD
Argatroban—F2—Hemostasis—AKT1—type 2 diabetes mellitus	1.57e-05	0.00014	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.57e-05	0.000139	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.57e-05	0.000139	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.56e-05	0.000138	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.55e-05	0.000138	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.55e-05	0.000138	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.53e-05	0.000136	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.52e-05	0.000135	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.52e-05	0.000135	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.52e-05	0.000135	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.52e-05	0.000135	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.52e-05	0.000135	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	1.5e-05	0.000133	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	1.5e-05	0.000133	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	1.5e-05	0.000133	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	1.47e-05	0.00013	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.47e-05	0.00013	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.46e-05	0.00013	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	1.46e-05	0.000129	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	1.43e-05	0.000126	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.39e-05	0.000123	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.39e-05	0.000123	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.38e-05	0.000123	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	1.37e-05	0.000122	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	1.35e-05	0.00012	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	1.35e-05	0.00012	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.35e-05	0.00012	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—INS—type 2 diabetes mellitus	1.32e-05	0.000117	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	1.32e-05	0.000117	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.3e-05	0.000116	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	1.3e-05	0.000115	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	1.3e-05	0.000115	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.29e-05	0.000114	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.29e-05	0.000114	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.29e-05	0.000114	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.28e-05	0.000114	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.28e-05	0.000114	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.27e-05	0.000113	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.24e-05	0.00011	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.24e-05	0.00011	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.22e-05	0.000108	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.19e-05	0.000106	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.19e-05	0.000106	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.17e-05	0.000104	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.16e-05	0.000103	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.16e-05	0.000103	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.15e-05	0.000102	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.15e-05	0.000102	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.15e-05	0.000102	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.12e-05	9.93e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	1.12e-05	9.93e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	1.11e-05	9.88e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	1.1e-05	9.75e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.09e-05	9.7e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.08e-05	9.59e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	1.07e-05	9.47e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	1.04e-05	9.21e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	1.02e-05	9.04e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.01e-05	8.98e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	9.97e-06	8.85e-05	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.95e-06	8.83e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	9.94e-06	8.82e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.86e-06	8.75e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.79e-06	8.69e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9.77e-06	8.67e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9.77e-06	8.67e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9.77e-06	8.67e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9.77e-06	8.67e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	9.68e-06	8.59e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	9.56e-06	8.48e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	9.37e-06	8.31e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.32e-06	8.27e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.22e-06	8.18e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	9.17e-06	8.14e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.04e-06	8.02e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	9e-06	7.99e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	8.72e-06	7.73e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.71e-06	7.73e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.59e-06	7.62e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	8.57e-06	7.6e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	8.54e-06	7.58e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	8.44e-06	7.49e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.37e-06	7.42e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	8.13e-06	7.21e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.96e-06	7.07e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.96e-06	7.07e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.81e-06	6.93e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.76e-06	6.89e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.76e-06	6.89e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.76e-06	6.89e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.71e-06	6.84e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.68e-06	6.81e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7.58e-06	6.72e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.53e-06	6.68e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.49e-06	6.64e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	7.44e-06	6.6e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	7.3e-06	6.47e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.96e-06	6.18e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.96e-06	6.18e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.96e-06	6.18e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.83e-06	6.06e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.77e-06	6.01e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	6.69e-06	5.93e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.63e-06	5.88e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	6.4e-06	5.68e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	6.4e-06	5.68e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.37e-06	5.65e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.3e-06	5.59e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.3e-06	5.59e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	6.04e-06	5.36e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	6.04e-06	5.36e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	5.85e-06	5.19e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.79e-06	5.13e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.34e-06	4.74e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.2e-06	4.62e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.2e-06	4.62e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.18e-06	4.6e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.11e-06	4.53e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.96e-06	4.4e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.83e-06	4.28e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.74e-06	4.2e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.64e-06	4.11e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.62e-06	4.1e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.5e-06	3.99e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.44e-06	3.94e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.26e-06	3.78e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.18e-06	3.71e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.05e-06	3.6e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.98e-06	3.54e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.97e-06	3.52e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.92e-06	3.48e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.46e-06	3.07e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.39e-06	3.01e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.11e-06	2.76e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.97e-06	2.64e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.97e-06	2.64e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	2.94e-06	2.61e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.72e-06	2.41e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.37e-06	1.21e-05	CbGpPWpGaD
